Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1990-04-06
1992-02-25
Gerstl, Robert
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
548125, C07D27301, A61K 3141
Patent
active
050913980
ABSTRACT:
The 1,2,3,4-oxatriazolium-5-olates of the formula I ##STR1## in which R.sup.1 denotes, for example, (C.sub.2 to C.sub.4)alkyl,
REFERENCES:
patent: 3427317 (1969-07-01), Kier
Kier, J. Pharm. Sci. 55 1467 (1966).
Beyerle Rudi
Bohn Helmut
Just Melitta
Schonafinger Karl
Cassella Aktiengellschaft
Gerstl Robert
LandOfFree
Substituted 1,2,3,4-oxatriazolium-5-olates, a process for their does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substituted 1,2,3,4-oxatriazolium-5-olates, a process for their , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted 1,2,3,4-oxatriazolium-5-olates, a process for their will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1893187